Cargando…
Tumour neoantigen mimicry by microbial species in cancer immunotherapy
Tumour neoantigens arising from cancer-specific mutations generate a molecular fingerprint that has a definite specificity for cancer. Although this fingerprint perfectly discriminates cancer from healthy somatic and germline cells, and is therefore therapeutically exploitable using immune checkpoin...
Autores principales: | Boesch, Maximilian, Baty, Florent, Rothschild, Sacha I., Tamm, Michael, Joerger, Markus, Früh, Martin, Brutsche, Martin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329167/ https://www.ncbi.nlm.nih.gov/pubmed/33824481 http://dx.doi.org/10.1038/s41416-021-01365-2 |
Ejemplares similares
-
Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer
por: Boesch, Maximilian, et al.
Publicado: (2021) -
Non-pharmaceutical interventions to optimize cancer immunotherapy
por: Boesch, Maximilian, et al.
Publicado: (2023) -
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
por: Baty, Florent, et al.
Publicado: (2017) -
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects
por: Boesch, Maximilian, et al.
Publicado: (2022) -
OMIP 077: Definition of all principal human leukocyte populations using a broadly applicable 14‐color panel
por: Boesch, Maximilian, et al.
Publicado: (2021)